Skip to content
healthcare.dev

Lisdexamfetamine dimesylate

NDC 72205-137, Lisdexamfetamine dimesylate, tablet, chewable, from Novadoz Pharmaceuticals LLC.

Product NDC
72205-137
Status
Listed
Labeler
Novadoz Pharmaceuticals LLC
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218306
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72205-137 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE60 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
72205-137-9172205013791100 TABLET, CHEWABLE in 1 BOTTLE (72205-137-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811
  • NADAC price for package 72205013791

    GET /v1/drugs/nadac/72205013791

Use it

Look up 72205-137 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72205-137 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72205-137. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.